Document is current
Any future updates will be listed below
-
Authors
da Silva Machado, Daniel Gomes https://orcid.org/0000-0002-8426-0488
Bikson, Marom https://orcid.org/0000-0002-0493-8333
Datta, Abhishek https://orcid.org/0000-0001-8833-6956
Caparelli-Dáquer, Egas https://orcid.org/0000-0002-5026-7665
Unal, Gozde
Baptista, Abrahão F. https://orcid.org/0000-0001-7870-3820
Cyrino, Edilson Serpeloni https://orcid.org/0000-0001-9016-8779
Li, Li Min
Morya, Edgard https://orcid.org/0000-0003-0954-5317
Moreira, Alexandre https://orcid.org/0000-0002-4609-1839
Okano, Alexandre Hideki https://orcid.org/0000-0002-8995-1392
-
Funding
Funding for this research was provided by:
National Institutes of Health
Conselho Nacional de Desenvolvimento Científico e Tecnológico
- License Information
-
More Information
Article History
Received: 2 October 2020
Accepted: 3 June 2021
First Online: 6 July 2021
Competing interests
: DGSM, ECD, GU, AFB, ESC, LML, EM, AM, and AHO declare they have no conflict of interest concerning the content of this manuscript. The City University of New York holds patents on brain stimulation with MB as an inventor. MB has equity in Soterix Medical Inc. MB consults, received grants, assigned inventions, and/or serves on the SAB of Boston Scientific, GlaxoSmithKline, Mecta, Halo Neuroscience, X. Dr. Datta has equity in Soterix Medical, Inc., a startup company that aims to commercialize HD-tDCS. Dr. Datta also has patent rights to HD-tDCS technology.
